| Bioactivity | MAX-40279 hemifumarate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1]. |
| Target | FLT3 and FGFR |
| Name | MAX-40279 hemifumarate |
| CAS | 2388506-43-0 |
| Formula | C22H23FN6OS.1/2C4H4O4 |
| Molar Mass | 554.59 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1. |
MAX-40279 hemifumarate
CAS: 2388506-43-0 F: C22H23FN6OS.1/2C4H4O4 W: 554.59
MAX-40279 hemifumarate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate has the pot
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.